Skip to main content
Singapore Clinical Research Institute will NEVER ask you to transfer money or disclose bank details over a call.

If in doubt, call the 24/7 ScamShield helpline at 1799, or visit the ScamShield website at www.scamshield.gov.sg (opens in new tab).

Singapore Clinical Research Institute (SCRI)

Prof Tony SK Mok

Meet Prof. Tony SK Mok, a leading lung cancer researcher and Chairman of Clinical Oncology at The Chinese University of Hong Kong.

Last updated on 2 October 2026
Man with glasses and dark blazer over white shirt, arms crossed, posing confidently indoors.

Prof. Tony SK Mok
Chairman, Department of Clinical Oncology
Li Shu Fan Professor of Clinical Oncology

Prof. Tony S. K. Mok trained at the University of Alberta, Canada and subsequently completed a fellowship in medical oncology at the Princess Margaret Hospital in Canada. After working as a community oncologist in Toronto, Canada for seven years, he returned to Hong Kong in 1996 to pursue an academic career.

He is Li Shu Fan Medical Foundation Named Professor and Chairman of Clinical Oncology at The Chinese University of Hong Kong, Hong Kong. His main research interest focuses on biomarker and molecular targeted therapy in lung cancer. He co-founded the Lung Cancer Research Group, and has led a number of important multinational clinical trials, which include the IPASS, FASTAST 2, IMPRESS and PROFILE 1014 that contributed to the current standard of practice on management of advanced stage lung cancer.

Prof. Mok has contributed to over 185 articles in international peer-reviewed journals, including the New England Journal of Medicine, Science, Lancet and Journal of Clinical Oncology, and contributed to multiple editorials and textbooks. He is active and experienced in serving the academic societies. He is the Past President of the International Association for the Study Of Lung Cancer (IASLC), Past Chair of the American Society of Clinical Oncology (ASCO) International Affairs Committee, a member of the ASCO Publications Committee and Vice Secretary of the Chinese Society of Clinical Oncology (CSCO).

He is closely affiliated with the oncology community in China, and has received an Honorary Professorship at Guang Dong Province People’s Hospital, Guest Professorship at Peking University School of Oncology, Visiting Professorship at Shanghai Jiao Tong University and West China School of Medicine/West China Hospital, Sichuan University. He is an Editor on Thoracic Oncology for Journal of Clinical Oncology. He has also authored six books in Chinese and hosted three television series in Hong Kong.